Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by core impairments in social communication as well as restricted, repetitive patterns of behavior and/or interests. Individuals with ASD, which includes about 2% of the US population, have challenges with activities of da...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Lauren M., Smith, Elizabeth G., Pedapati, Ernest V., Horn, Paul S., Will, Meredith, Lamy, Martine, Barber, Lillian, Trebley, Joe, Meyer, Kevin, Heiman, Mark, West, Korbin H. J., Hughes, Phoevos, Ahuja, Sanjeev, Erickson, Craig A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061375/
https://www.ncbi.nlm.nih.gov/pubmed/36997569
http://dx.doi.org/10.1038/s41598-023-30909-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061375/
https://www.ncbi.nlm.nih.gov/pubmed/36997569
http://dx.doi.org/10.1038/s41598-023-30909-0

Ejemplares similares